• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,409.98 254.36
( 0.33%)
Global Indices
Nasdaq
51,515.27 -505.40
(-0.97%)
Dow Jones
7,441.22 -91.13
(-1.21%)
Hang Seng
71,050.31 1,148.06
(1.64%)
Nikkei 225
10,505.62 11.41
(0.11%)
Forex
USD-INR
94.55 -0.09
(-0.09%)
EUR-INR
109.66 -0.13
(-0.12%)
GBP-INR
126.84 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
27.4543251
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
9.42
29.09
EPS(TTM)
Face Value()
Div & Yield %
3.6
10
0
 

shree metalloys ltd
Shukra Pharmaceuticals standalone net profit rises 544.30% in the December 2025 quarter
Feb 04,2026
Net profit of Shukra Pharmaceuticals rose 544.30% to Rs 20.36 crore in the quarter ended December 2025 as against Rs 3.16 crore during the previous quarter ended December 2024. Sales rose 269.85% to Rs 39.13 crore in the quarter ended December 2025 as against Rs 10.58 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales39.1310.58 270
OPM %69.3137.15 -
PBDT27.664.79 477
PBT26.824.09 556
NP20.363.16 544